The stark rise in the production of synthetic drugs such as (meth-)amphetamines poses increasing challenges for prosecutors across Europe. By rapidly changing the composition of chemicals used for these drugs – as, for instance, red phosphorus, MAPA and APAA – or creating new substances, producers try to exploit legal gaps and avoid prosecution. Also, due to legal uncertainties, it is often difficult to prove suppliers are deliberately selling illegal drugs or substances. Furthermore, the sale of synthetic drugs via online marketplaces, particularly on the darknet, is an obstacle for prosecutions and seriously harms public health. These are some of the main conclusions of the new Eurojust Report on Drug Trafficking. Illicit drug trafficking across the EU is generally growing strongly, with an estimated value of at least EUR 30 billion. The report gives further recommendations to increase financial investigations, asset recovery and judicial cooperation, including with third countries. Continue reading…
Gone are the days when organisations could simply promise a speak up culture. Today, fostering a culture of trust, integrity, and a positive work environment…
Download whitepaper